Treating Non-Hodgkin Lymphoma

At Scott & White, You’re Treated as a Person, Not a Diagnosis
Our Tumor Board Sets Us Apart

As a non-Hodgkin lymphoma patient at Scott & White, in addition to having a highly experienced Integrated Care Team, you’ll also benefit from the expertise of the Scott & White Tumor Board.

Led by senior staff, our multidisciplinary board consists of blood malignancy experts who discuss available approaches to care and formulate patient-specific treatment plans. This treatment planning helps ensure you receive the highest quality, individualized care.

Scott & White Spearheads Progressive New Lymphoma Treatments

The key to curing non-Hodgkin lymphoma lies in developing new treatments. And we’re working on that here. Scott & White Cancer Institute leads the way in developing innovative new treatments for lymphoma and other blood disorders.

Talk to your physician about whether you’re a candidate for participating in one of our clinical trials.

One of our faculty members is involved in research, developing some of these new and innovative agents. And some of those agents are available only here at our institution for clinical trial. So I think when we get through patients who've been treated with standard medicines, and have had relapses, there are some additional options here that might not be available at the routine private practice hematology clinic.

Mark H. Holguin, MD, Hematology/Oncology; Chief – Section of Hematology

Lymphomas are often many times treatable and curable. You have good chances for cure with aggressive non-Hodgkin lymphoma. With the indolent non-Hodgkin lymphoma, though there may not be a chance for cure, the likelihood of living for many years is high.

Mark H. Holguin, MD, Hematology/Oncology; Chief – Section of Hematology

Non-Hodgkin lymphoma (NHL) is a highly complex disease: two types of NHLs with about 35 subtypes. You’ll need a highly skilled, multidisciplinary team to clinically manage the many complexities of care.

Our nationally recognized interdisciplinary group of medical professionals — hematopathologists, cytopathologists, and many others — will assist your hematologist/oncologists in offering you the most advanced therapies and procedures available in managing your non-Hodgkin lymphoma.

The hallmark of our Lymphoma Team is experience. We’ve got the know-how to control or cure your NHL. Our blood cancer specialists have unparalleled skill and expertise. You can have confidence in us. You can look forward to many years of life with this disease behind you.

As a Scott & White patient, you’ll also benefit from having a multidisciplinary team — your Integrated Care Team — working together to provide you with the best care possible at all stages of your lymphoma treatment.

The members of your Integrated Care Team bring together the collective skill and expertise from all the specialties and subspecialties involved in your care, which can include:

Integrated Care Team members receive training in the most up-to-date surgical, radiation and medical therapies. And because Scott & White is a research institute and a teaching hospital, our oncologists can offer you the most advanced treatments available. We lead the way in developing new therapies.

Our patients benefit by having a large group of doctors and a team review their cases together to come up with a consensus plan. Even though, of course, it's tailored to them specifically.

Juddi Yeh, MD, Hematology/Oncology – College Station Clinic

Back to Top

Collaborative Care and Expertise Help Ensure the Best Outcome for You

Sophisticated cancer care takes teamwork. That’s why Scott & White promotes a collaborative environment

Your Integrated Care Team will met to discuss your specific needs and determine the best treatment options for you to consider. Then your lead physician will talk with you and, if you’d like, your family, about the team’s recommendations.

Together, you and your lead physician will decide which treatment choice is best for you.

Throughout your treatment, your physicians will continue to meet regularly to discuss your care. This ongoing, close collaboration helps ensure the best outcome for you.

Following active treatment, your Integrated Care Team will work with you to create the most appropriate follow-up care plan.

Factors That Impact Your Treatment

Your treatment options for non-Hodgkin lymphoma generally depend on these factors:

  • The type and subtype of non-Hodgkin lymphoma you have
  • Your age and general health
  • Your personal preference

When I see patients, they do tend to have a lot of questions—a lot of unanswered questions at that point—and so the first appointment tends to be a fairly extensive appointment, at which time we talk about the disease, the disease process, what to expect, and what we can do to help them.

Christal Murray, MD, Hematology/Oncology

Back to Top

Your Treatment Options

At Scott & White, we explore every treatment option. In many cases, your non-Hodgkin lymphoma treatment will include a combination of approaches. Treatment options include:

Treatment goals for non-Hodgkin lymphoma depend on whether your NHL is indolent or aggressive. 

Indolent NHL Subtypes

Indolent non-Hodgkin lymphoma advances slowly. Treatment options for indolent NHL range from active surveillance to immediate chemotherapy. Your physician team will discuss which options are best for you.

The treatment goal for indolent NHL is remission. Research shows that because indolent NHL is generally not considered curable and treatment doesn’t necessarily prolong life, it does help control symptoms associated with indolent NHL.

Aggressive NHL Subtypes

Aggressive non-Hodgkin lymphoma advances rapidly and may spread to your bones or your central nervous system. Your physician team may recommend chemotherapy as first-line treatment for aggressive NHL.

The treatment goal for aggressive NHL is cure.

Back to Top

Text Size